#Bioactive Compound

[kishorxox]

Botanicals Market Size, Share, Forecast, & Trends Analysis

Meticulous Research®—a leading global market research company, published a research report titled ‘Botanicals Market—Global Opportunity Analysis and Industry Forecast (2025-2032)’. According to this latest publication, the Botanicals market is expected to reach $24.97 billion by 2032, at a CAGR of 9.0% from 2025 to 2032.

The growth of the botanicals market is experiencing growth due to the rising demand for botanicals in the food and beverage sector, increased consumer awareness regarding the health benefits of botanical extracts, expansion within the cosmetics and personal care industries, and an increasing preference for natural and organic products. However, this growth is restrained by factors such as volatility in raw material prices, the widespread availability of synthetic alternatives, and issues related to standardization and quality consistency.

In addition, regulatory support and a growing demand for vegan beauty products present significant opportunities for the players operating in this market. Furthermore, the rising adoption of clean-label products and an increasing awareness of health and wellness are prominent trends shaping the botanicals market.

Key Players:

The botanicals market is characterized by a moderately competitive scenario due to the presence of many large- and small-sized global, regional, and local players. The key players operating in the botanicals market are International Flavors & Fragrances (U.S.), MB-Holding GmbH & Co. K.G. (Germany), Givaudan SA (Switzerland), Bell Flavors& Fragrances (U.S.), Synergy Flavors (U.S.), Blue Sky Botanics Ltd. (U.K.), Dohler GmbH (Germany), Synthite Industries Ltd. (India), Cargill, Incorporated (U.S.), Kalsec Inc. (U.S.), Nexira (U.S.), Botanical Ingredients Ltd. (Australia), Lipoid Kosmetic AG (Switzerland), and Nutra Green Biotechnology Co., Ltd. (China).

The botanicals market is segmented based on product type and distribution channel. This study also evaluates industry competitors and analyzes the regional and country-level markets.

Among the product studied in this report, the garlic extract segment is anticipated to hold the dominant position, with a share of 30—35% of the market in 2025. This segment's significant market share is primarily driven by its diverse medicinal properties, including support for cardiovascular health, enhancement of the immune system, and anti-inflammatory effects. Furthermore, its broad applications across the food and beverage, cosmetics, and pharmaceutical industries, along with its strong antimicrobial properties, contribute significantly to market growth.

Among the form studied in this report, the powder segment is anticipated to hold the dominant position, with a large share of the botanicals market in 2025. This segment's significant market share is attributed to its versatility in applications, allowing for seamless integration into various formulations. Its cost-effectiveness, resulting from straightforward production processes, coupled with a comprehensive range of active components, further enhances its appeal in the market.

Among the nature studied in this report, the non-organic segment is anticipated to hold the dominant position, with a large share of the botanicals market in 2025. This segment's significant market share is largely due to the widespread availability of non-organic botanical extracts, as many companies offer these products without organic certifications. Additionally, a large base of cost-conscious consumers who prioritize price over organic certification—especially when the perceived health benefits of non-organic botanicals are viewed as comparable to those of their organic counterparts—further drives market growth.

Among the application studied in this report, the cosmetics and personal care segment is anticipated to hold the dominant position, with a large share of the botanicals market in 2025. This segment's significant market share is driven by the expansive global cosmetics and personal care industry and a growing consumer preference for natural and organic ingredients.

This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Netherlands, Poland, Belgium, and Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentina, and Rest of Latin America), and the Middle East & Africa.

Among the geographies studied in this report, Europe is anticipated to hold the dominant position, with aa share of 35.8% of the market in 2025, followed by North America and Asia-Pacific. North America's botanicals market is estimated to be worth USD 4.64 billion in 2025. The significant share of this regional market is driven by several key factors, including increased awareness of natural and organic products, increased consumer spending on health and wellness items, stringent regional regulations governing the use of synthetic ingredients across various industries, and the widespread adoption of natural ingredients in personal care and cosmetics.

Download Sample Report: https://www.meticulousresearch.com/download-sample-report/cp_id=6021

Key Questions Answered in the Report-

What is the value of revenue generated by the sale of botanicals?

At what rate is the global demand for botanicals projected to grow for the next five to seven years?

What is the historical market size and growth rate for the botanicals market?

What are the major factors impacting the growth of this market at global and regional levels?

What are the major opportunities for existing players and new entrants in the market?

Which product, form, nature, and application segments create major traction for the manufacturers in this market?

What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the manufacturers operating in the botanicals market?

Who are the major players in the botanicals market? What are their specific product offerings in this market?

What recent developments have taken place in the botanicals market? What impact have these strategic developments created on the market?

Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

[hinge]

Hinge presents an anthology of love stories almost never told. Read more on https://no-ordinary-love.co

[turniponatuesday]

Replanted everything in my closed terrarium with some native mosses and other plants I found outside 🫙🦷💀🪴

Dont worry, the springtails are just fine

[bioactivesx]

Bioactive Compounds Research - Bio Actives Export is a leading bioactive compounds research lab based in Australia, specializing in the exploration and development of natural compounds with significant health benefits. Our cutting-edge research focuses on identifying, isolating, and testing bioactive compounds found in plants, herbs, and other natural sources to improve human health, food quality, and pharmaceutical applications.

[lerariemann]

just for fun you say

oh look i moved the rings around!

fuck this one carbon atom tbh

[reviewsandotherstuff]

U Beauty Review

Happy sweater weather, everyone. It is that time of the season when we need to add extra protection to our skin. The Fall and Winter seasons can make our skin dry. We all know that dry skin can be challenging to deal with. The more you let your skin dry, the more it becomes prone to other issues, such as cracking, itching, and even unnecessary breakouts or infections due to broken skin…

[reasonsforhope]

"A team at Northwestern University has come up with the term “dancing molecules” to describe an invention of synthetic nanofibers which they say have the potential to quicken the regeneration of cartilage damage beyond what our body is capable of.

The moniker was coined back in November 2021, when the same team introduced an injection of these molecules to repair tissues and reverse paralysis after severe spinal cord injuries in mice.

Now they’ve applied the same therapeutic strategy to damaged human cartilage cells. In a new study, published in the Journal of the American Chemical Society, the treatment activated the gene expression necessary to regenerate cartilage within just four hours.

And, after only three days, the human cells produced protein components needed for cartilage regeneration, something humans can’t do in adulthood.

The conceptual mechanisms of the dancing molecules work through cellular receptors located on the exterior of the cell membrane. These receptors are the gateways for thousands of compounds that run a myriad of processes in biology, but they exist in dense crowds constantly moving about on the cell membrane.

The dancing molecules quickly form synthetic nanofibers that move according to their chemical structure. They mimic the extracellular matrix of the surrounding tissue, and by ‘dancing’ these fibers can keep up with the movement of the cell receptors. By adding biological signaling receptors, the whole assemblage can functionally move and communicate with cells like natural biology.

“Cellular receptors constantly move around,” said Northwestern Professor of Materials Sciences Samuel Stupp, who led the study. “By making our molecules move, ‘dance’ or even leap temporarily out of these structures, known as supramolecular polymers, they are able to connect more effectively with receptors.”

The target of their work is the nearly 530 million people around the globe living with osteoarthritis, a degenerative disease in which tissues in joints break down over time, resulting in one of the most common forms of morbidity and disability.

“Current treatments aim to slow disease progression or postpone inevitable joint replacement,” Stupp said. “There are no regenerative options because humans do not have an inherent capacity to regenerate cartilage in adulthood.”

In the new study, Stupp and his team looked to the receptors for a specific protein critical for cartilage formation and maintenance. To target this receptor, the team developed a new circular peptide that mimics the bioactive signal of the protein, which is called transforming growth factor beta-1 (TGFb-1).

Northwestern U. Press then reported that the researchers incorporated this peptide into two different molecules that interact to form supramolecular polymers in water, each with the same ability to mimic TGFb-1...

“With the success of the study in human cartilage cells, we predict that cartilage regeneration will be greatly enhanced when used in highly translational pre-clinical models,” Stupp said. “It should develop into a novel bioactive material for regeneration of cartilage tissue in joints.”

“We are beginning to see the tremendous breadth of conditions that this fundamental discovery on ‘dancing molecules’ could apply to,” Stupp said. “Controlling supramolecular motion through chemical design appears to be a powerful tool to increase efficacy for a range of regenerative therapies.”"

-via Good News Network, August 5, 2024

[mindblowingscience]

The industrially ravaged Gowanus Canal, long regarded as a symbol of urban environmental neglect, is being reimagined through the lens of scientific inquiry as a complex reservoir of microbial life shaped by intense selective pressures. Research led by NYU Tandon School of Engineering has discovered microbes in Brooklyn's Gowanus Canal that carry genes for breaking down industrial pollutants and neutralizing heavy metals. Genetic screening also uncovered resistance to multiple antibiotic classes and thousands of biosynthetic gene clusters with implications for developing new antibiotics, industrial enzymes, and bioactive compounds.

Continue Reading.

[beardedmrbean]

A deadly fungus has been turned into a potent cancer-fighting compound after researchers isolated a new class of molecules from it.

Aspergillus flavus, a toxic crop fungus linked to deaths in the excavations of ancient tombs—such as that of the boy pharaoh Tutankhamon—was recently used in a test against leukemia cells.

The result? A promising cancer-killing compound that rivals FDA-approved drugs and opens up new frontiers in the discovery of more fungal medicines.

“Fungi gave us penicillin,” says Sherry Gao, Presidential Compact Associate Professor at the University of Pennsylvania and senior author of a new paper in Nature Chemical Biologyon. “These results show that many more medicines derived from natural products remain to be found.”

After archaeologists opened King Tutankhamun’s tomb in the 1920s, a series of untimely deaths among the excavation team fueled rumors of a pharaoh’s curse. Decades later, doctors theorized that fungal spores, dormant for millennia, could have played a role.

In the 1970s, a dozen scientists entered the tomb of Casimir IV in Poland. Within weeks, 10 of them died. Later investigations revealed the tomb contained Aspergillus flavus, named for its yellow spores, whose toxins can lead to lung infections, especially in people with compromised immune systems.

Now, that same fungus is the unlikely source of a promising new cancer therapy.

The therapy in question is a class of ribosomally synthesized and post-translationally modified peptides, or RiPPs, pronounced like the “rip” in a piece of fabric. The name refers the ribosome, a tiny cellular structure that makes proteins, including RiPP.

“Purifying these chemicals is difficult,” says Qiuyue Nie, a postdoctoral fellow and the paper’s first author. While thousands of RiPPs have been identified in bacteria, only a handful have been found in fungi. In part, this is because past researchers misidentified fungal RiPPs as non-ribosomal peptides and had little understanding of how fungi created the molecules.

“The synthesis of these compounds is complicated,” adds Nie. “But that’s also what gives them this remarkable bioactivity.”

To find more fungal RiPPs, the researchers first scanned a dozen strains of Aspergillus, which previous research suggested might contain more of the chemicals. By comparing chemicals produced by these strains with known RiPP building blocks, the researchers identified A. flavus as a promising candidate for further study.

Genetic analysis pointed to a particular protein in A. flavus as a source of fungal RiPPs. When the researchers turned the genes that create that protein off, the chemical markers indicating the presence of RiPPs also disappeared.

This novel approach of combining metabolic and genetic information not only pinpointed the source of fungal RiPPs in A. flavus but could be used to find more fungal RiPPs in the future.

After purifying four different RiPPs, the researchers found the molecules shared a unique structure of interlocking rings. The researchers named these molecules, which have never been previously described, after the fungus in which they were found: asperigimycins.

Even with no modification, when mixed with human cancer cells, asperigimycins demonstrated medical potential: two of the four variants had potent effects against leukemia cells.

OTHER GIFTS FROM THE WORLD OF FUNGI: Ingredient Found in All Mushrooms Can Reprogram Immune Cells to Fight Deadly Flu Infections

Another variant, to which the researchers added a lipid, or fatty molecule, that is also found in the royal jelly that nourishes developing bees, performed as well as cytarabine and daunorubicin, two FDA-approved drugs that have been used for decades to treat leukemia.

Inside the leukemia cells, a gene called SLC46A3, proved critical in allowing asperigimycins to enter leukemia cells in sufficient numbers, which has given the team the idea that it might be a pathway for other, already developed remedies called cyclic peptides, to enter and kill a leukemia cell.

“Knowing that lipids can affect how this gene transports chemicals into cells gives us another tool for drug development,” says Nie.

Through further experimentation, the researchers found that asperigimycins likely disrupt the process of cell division. Notably, the compounds had little to no effect on breast, liver or lung cancer cells, or a range of bacteria and fungi, suggesting that asperigimycins’ disruptive effects are specific to certain types of cells, a critical feature for any future medication.

NOVEL CANCER TREATMENTS: Scientists Identify New Way Cancers Sustain Themselves–and How Ginger Could Disrupt it

In addition to demonstrating the medical potential of asperigimycins, the researchers identified similar clusters of genes in other fungi, suggesting that more fungal RiPPs remain to be discovered.

“Even though only a few have been found, almost all of them have strong bioactivity,” says Nie. “This is an unexplored region with tremendous potential.”

“Nature has given us this incredible pharmacy,” says Gao. “It’s up to us to uncover its secrets. As engineers, we’re excited to keep exploring, learning from nature and using that knowledge to design better solutions.”

[reality-detective]

Instead of throwing away corn silk, consider using it to make tea!

Instructions: 👇

1. Gather corn silk from 3-4 corn cobs.

2. Thoroughly clean the corn silk.

3. Add about 4 cups of water.

4. Cook on low heat for 15 minutes or until it reduces by half.

5. Strain the tea and enjoy it hot or cold.

Corn silk contains: 👇

Nutrients like proteins, carbohydrates, vitamins, minerals, fiber, calcium, potassium, magnesium, sodium, iron, zinc, and chloride. Bioactive phytochemical compounds, such as phenols, polyphenols, phenolic acids, flavonoids, flavone glycosides, anthocyanins, carotenoids, terpenoids, alkaloids, and steroids. 🤔

[boymosher-420]

Dandelion has been used for centuries in traditional medicine due to its numerous health benefits. Here are five key ways dandelion heals:

1. *Liver and Kidney Support*: Dandelion acts as a natural diuretic, flushing toxins from the liver and kidneys, and its antioxidants protect the liver from inflammation and oxidative stress.

2. *Nutrient-Rich Superfood*: Dandelion greens are packed with vitamins A, C, and K, and essential minerals like calcium, iron, and potassium, supporting immune health, bone strength, and overall wellness.

3. *Digestive Aid*: Bitter compounds in dandelion greens stimulate digestion, promote a healthy gut, and alleviate indigestion, bloating, and constipation.

4. *Anti-Inflammatory Properties*: Bioactive compounds like polyphenols and flavonoids in dandelions reduce inflammation, potentially easing symptoms of arthritis and other inflammatory conditions.

5. *Blood Sugar Regulation*: Dandelions may help regulate blood sugar and improve insulin sensitivity, benefiting those with diabetes or at risk of developing the condition.

To harness dandelion's healing potential, you can consume it in various ways, such as:

- Adding fresh greens to salads

- Drinking dandelion tea

- Blending greens into smoothies

- Taking supplements (after consulting a healthcare provider)

Remember to start with small amounts and consult a healthcare provider if you have allergies or are pregnant/breastfeeding.

[bloom-wellness-group]

What happens if a male uses your products? I have no problem having big milky tits but any side effects?

Great question!

MilkyMama Treats™ were scientifically formulated by our partners at Nurtiva Labs to work exclusively with XX chromosomes—the genetic signature of biological females. Each treat contains bioactive compounds that bind to estrogen receptors and activate the lactation pathways unique to female anatomy.

These compounds:

Stimulate mammary gland growth

Boost prolactin levels

Enhance fat distribution to the chest, hips, and thighs

But here’s the short and sweet truth:

> No XX chromosomes? No milk. No curves. No transformation.

Even with elevated estrogen levels, male bodies lack the core genetic and hormonal conditions required for the Treat’s effects to activate. So while a man could eat one, the most he’ll get is a sugar kick—not a new figure.

That said… stay tuned. Products designed specifically for our XY friends are cuming soon.

Let’s just say… we’re working on something that’ll make sure he can keep up with the women of today.

[darkmaga-returns]

by Nicolas Hulscher, MPH

As the U.S. begins to escalate their response against H5N1 bird flu, we will likely see a push for more unsafe and ineffective countermeasures. The Biopharmaceutical Complex is currently preparing bird flu mRNA injections developed by Moderna, CEPI-funded H5N1 replicon (self-amplifying) shots, and Arcturus Therapeutics replicon ‘pandemic’ bird flu injections funded by BARDA and the Gates Foundation. Thus, it is of high priority to identify promising compounds with anti-avian influenza activity that don’t involve injection of modified genetic material.

A 2023 study revealed a comprehensive list of natural plants and bioactive compounds that have shown anti-avian influenza activity: A systemic review on medicinal plants and their bioactive constituents against avian influenza and further confirmation through in-silico analysis.

Methods: 33 plants and 4 natural compounds were identified and documented. Molecular docking was performed against the target viral protein neuraminidase (NA), with some plant based natural compounds and compared their results with standard drugs Oseltamivir and Zanamivir to obtain novel drug targets for influenza. Results: It was seen that most extracts exhibit their action by interacting with viral hemagglutinin or neuraminidase and inhibit viral entry or release from the host cell. Some plants also interacted with the viral RNA replication or by reducing proinflammatory cytokines. Ethanol was mostly used for extraction. Among all the plants Theobroma cacao, Capparis Sinaica Veil, Androgarphis paniculate, Thallasodendron cillatum, Sinularia candidula, Larcifomes officinalis, Lenzites betulina, Datronia molis, Trametes gibbose exhibited their activity with least concentration (below 10 μg/ ml). The docking results showed that some natural compounds (5,7- dimethoxyflavone, Aloe emodin, Anthocyanins, Quercetin, Hemanthamine, Lyocrine, Terpenoid EA showed satisfactory binding affinity and binding specificity with viral neuraminidase compared to the synthetic drugs.